Levothyroxine (Thyronorm/Eltroxin) in India — Uses, Dosage, Price, Side Effects & Brand Comparison

Levothyroxine is the most prescribed medication in India that almost nobody takes correctly. Over 42 million Indians have hypothyroidism — 1 in every 10 adults — and the majority are on some form of this synthetic thyroid hormone. Thyronorm by Abbott dominates the market. Eltroxin by GSK is the legacy brand. Both contain the same molecule. And yet, switching between them can destabilize your thyroid levels for months.

This guide covers what your endocrinologist assumes you already know and what your chemist definitely won’t tell you — from why your morning chai is sabotaging your medication, to why the ₹70 Thyrox bottle is pharmacologically identical to the ₹145 Eltroxin one, to why ashwagandha supplements can push you into dangerous hyperthyroid territory.

---

What Is Levothyroxine and How Does It Work?

Levothyroxine is a synthetic version of thyroxine (T4), the hormone your thyroid gland produces naturally. It replaces the T4 your thyroid can no longer make in sufficient quantities — either because autoimmune destruction (Hashimoto’s thyroiditis) has damaged the gland, or because it was surgically removed, or because radioactive iodine treatment destroyed it.

What it is not:

• Not a weight loss drug. Hypothyroidism causes 2–5 kg of weight gain at most. Levothyroxine corrects that deficit — it doesn’t burn fat. Overprescribing for weight loss causes osteoporosis, atrial fibrillation, and anxiety.
• Not a cure. It replaces a hormone your body cannot produce. If the underlying cause is permanent (Hashimoto’s, thyroidectomy), you take it for life.
• Not optional. Untreated hypothyroidism causes progressive fatigue, depression, weight gain, high cholesterol, infertility, and in severe cases, myxedema coma — a medical emergency with 30–60% mortality.

Your body converts T4 into T3 (the active thyroid hormone) in peripheral tissues — liver, kidneys, muscles. Levothyroxine provides the raw material. Your body handles the conversion. This is why T4 replacement works for 85–90% of hypothyroid patients without needing separate T3 supplementation.

---

Who Needs Levothyroxine in India?

Condition	Prevalence in India	Levothyroxine Required?
Hashimoto’s thyroiditis (autoimmune)	~90% of all hypothyroidism	Yes — lifelong
Post-thyroidectomy	Surgical patients	Yes — lifelong
Post-radioactive iodine (RAI)	Graves’ disease patients	Yes — usually lifelong
Subclinical hypothyroidism (TSH 5–10)	~8% of Indian adults	Controversial — see below
Pregnancy with TSH >2.5	~2.5% of pregnancies	Yes — at least through pregnancy
Iodine deficiency hypothyroidism	Endemic in Himalayan belt	Sometimes — correcting iodine may suffice
Drug-induced (lithium, amiodarone)	Psychiatric/cardiac patients	Often — while on causative drug

India has a hypothyroidism epidemic. The landmark 2013 epidemiological study estimated that 10.95% of Indian adults have some form of hypothyroidism — clinical or subclinical. Women are affected 5–8 times more than men. The iodine belt (J&K, Himachal, Uttarakhand, Northeast) has even higher rates despite salt iodization programs.

The connection between thyroid problems and broader health conditions is well documented — hypothyroidism worsens diabetes management, contributes to depression, complicates pregnancy outcomes, and drives the PCOS-thyroid overlap that affects millions of Indian women.

---

The Subclinical Hypothyroidism Overtreatment Problem

This is where Indian endocrinology gets controversial.

Subclinical hypothyroidism means your TSH is mildly elevated (4.5–10 mIU/L) but your free T4 is normal. You may have no symptoms at all. Your lab report shows a flagged TSH, your doctor prescribes levothyroxine, and you’re on medication for life — for a condition that may never have caused you problems.

The 2023 Cochrane systematic review of 21 randomized controlled trials found no convincing evidence that treating subclinical hypothyroidism with levothyroxine improves quality of life, tiredness, depressive symptoms, or cardiovascular outcomes — when TSH is below 10 mIU/L.

Yet in India, millions are being prescribed levothyroxine for TSH values of 5–7 with normal T4. This is not evidence-based. It is defensive medicine.

When treatment IS justified for subclinical hypothyroidism:

1. TSH consistently above 10 mIU/L (even with normal T4)
2. Positive thyroid peroxidase (TPO) antibodies (indicates Hashimoto’s — will likely progress)
3. Pregnancy or planning pregnancy (target TSH <2.5)
4. Goiter (enlarged thyroid)
5. Significant symptoms attributable to thyroid dysfunction
6. Hyperlipidemia not responding to diet changes

When it is likely unnecessary:

• TSH 4.5–7 with normal T4, no antibodies, no symptoms
• Elderly patients over 70 (treatment may actually worsen cardiac outcomes)
• Single elevated TSH reading without confirmation at 6–8 weeks

If your doctor prescribed levothyroxine for a TSH of 5.5 and you feel perfectly fine, ask about watchful waiting with repeat testing in 3–6 months. You may not need medication at all.

---

Dosage Guide — How to Get It Right

Standard Dosing by Body Weight

The full replacement dose of levothyroxine is approximately 1.6 mcg per kg of body weight per day. But you almost never start at the full dose.

Body Weight	Estimated Full Replacement Dose
50 kg	75–80 mcg/day
60 kg	90–100 mcg/day
70 kg	100–112 mcg/day
80 kg	125–130 mcg/day
90 kg	140–150 mcg/day

Starting Doses by Patient Category

Patient	Starting Dose	Titration
Young healthy adult (<50, no cardiac history)	Full replacement dose	Recheck TSH at 6–8 weeks
Adult 50–65, no cardiac disease	25–50 mcg/day	Increase by 25 mcg every 6–8 weeks
Adult >65 or cardiac history	12.5–25 mcg/day	Increase by 12.5–25 mcg every 6–8 weeks
Severe longstanding hypothyroidism	12.5–25 mcg/day	Very slow titration — cardiac risk
Subclinical hypothyroidism	25–50 mcg/day	Recheck TSH at 6–8 weeks

The 6–8 week rule is non-negotiable. Levothyroxine has a half-life of 7 days. It takes 4–5 half-lives (4–5 weeks) to reach steady state. Retesting TSH before 6 weeks gives meaningless results. Any dose adjustment before that is guesswork.

Dose Titration — The Practical Reality

Most patients require 2–3 dose adjustments before finding their sweet spot. Here is what the process looks like:

1. Start dose → Wait 6–8 weeks → Recheck TSH
2. TSH still high? → Increase by 12.5–25 mcg → Wait 6–8 weeks → Recheck
3. TSH now low (overreplaced)? → Decrease by 12.5–25 mcg → Wait 6–8 weeks → Recheck
4. TSH in range (0.5–4.0 mIU/L)? → Maintain current dose → Recheck in 3–6 months → Then annually

Common Indian prescribing problem: Many general practitioners prescribe 50 mcg as a flat starting dose for everyone regardless of body weight, age, or cardiac status. A 45 kg woman and a 90 kg man get the same dose. This is lazy medicine. If your doctor does not ask your weight before prescribing, find a better doctor. Verifying doctor credentials is easier than you think.

---

How to Take Levothyroxine — The Indian Compliance Problem

The Rules

1. Empty stomach — at least 30 minutes, ideally 60 minutes before food
2. Plain water only — no chai, no milk, no coffee, no juice
3. No calcium supplements within 4 hours (including antacids like Tums/Digene)
4. No iron supplements within 4 hours
5. No soy-based foods within 4 hours (soy paneer, soy milk, soy chunks)
6. Same time every day — consistency matters as much as any individual rule

Why This Matters More Than You Think

Levothyroxine has a narrow therapeutic index — small changes in absorption cause clinically significant changes in blood levels. A 20–30% reduction in absorption from taking it with food is the equivalent of taking 50 mcg instead of 75 mcg. Your TSH will drift upward. Your doctor will increase the dose. Then one day you take it correctly on an empty stomach and you’re effectively overdosed.

Studies show that food reduces levothyroxine absorption by 20–40%. Coffee reduces it by ~30%. Calcium reduces it by 40%. Iron reduces it by 30–40%.

The Chai Problem

India’s biggest levothyroxine compliance issue is not forgetfulness. It is chai.

For hundreds of millions of Indians, the morning routine is: wake up → chai. Not wake up → swallow a pill with water → wait 45 minutes → chai. That 45-minute gap between the tablet and the first sip of chai is the single largest behavioral friction in thyroid management in India.

Practical solutions that actually work:

1. Bedtime dosing. Take levothyroxine at bedtime, at least 2–3 hours after dinner. Multiple studies show equivalent efficacy to morning dosing. Your morning chai stays untouched.
2. Pre-alarm strategy. Set an alarm 45 minutes before your actual wake-up time. Take the tablet. Go back to sleep. Wake up at your normal time and have chai normally.
3. Keep it at the bedside. Tablet + water glass on your nightstand. Take it the moment you open your eyes. By the time you’ve showered and dressed, 30+ minutes have passed.

What does NOT work: Taking the tablet with chai “because at least I’m taking it.” This is worse than skipping a dose occasionally, because it creates chronic under-absorption that looks like treatment failure on blood tests.

---

Brand Comparison — Thyronorm vs Eltroxin vs Thyrox vs Lethyrox

Price Comparison by Dosage (120 Tablets per Bottle)

Dosage	Thyronorm (Abbott)	Eltroxin (GSK)	Thyrox (Macleods)	Lethyrox (Intas)
25 mcg	₹70–95	₹85–110	₹50–70	₹55–75
50 mcg	₹95–125	₹115–145	₹70–95	₹75–100
75 mcg	₹110–140	₹130–160	₹85–110	₹90–115
100 mcg	₹125–155	₹145–180	₹95–125	₹100–130
125 mcg	₹140–170	₹160–195	₹110–140	₹115–145
150 mcg	₹155–185	₹175–210	₹120–150	₹125–155

Per tablet cost: ₹0.45–1.75 depending on brand and dosage. This makes levothyroxine one of the cheapest lifelong medications in India.

Monthly and Lifetime Cost Analysis

Brand Tier	Monthly Cost (75mcg)	Annual Cost	50-Year Lifetime Cost
Eltroxin (premium)	₹35–45	₹420–540	₹21,000–27,000
Thyronorm (market leader)	₹28–37	₹336–444	₹16,800–22,200
Thyrox/Lethyrox (value)	₹22–30	₹264–360	₹13,200–18,000
Jan Aushadhi generic	₹15–22	₹180–264	₹9,000–13,200

Total lifetime cost including annual TSH tests (₹300–500 each): ₹1.15–1.75 lakh over 50 years.

Compare this to the US: Synthroid (brand) costs $100–200/month, or $60,000–120,000 over 50 years. Even generic levothyroxine in the US runs $9,000–30,000 over a lifetime. India’s thyroid patients have it cheap — if they take the medication correctly.

The Market Share Reality

Thyronorm (Abbott) commands an estimated 55–60% of the Indian levothyroxine market. Eltroxin (GSK) holds about 20–25%. The rest is split among Macleods, Intas, Lupin, and Sun Pharma.

Thyronorm’s dominance is not because it is pharmacologically superior. It is because Abbott’s medical representative network in India is one of the most aggressive in the pharmaceutical industry. Doctors prescribe what reps promote. Patients accept what doctors prescribe. The market sorts itself by marketing spend, not by clinical data.

All brands contain the same active molecule — levothyroxine sodium — and must meet CDSCO bioequivalence standards. The differences are in inactive excipients: fillers, binders, dyes, and disintegrants. These inactive ingredients can marginally affect the rate and extent of absorption. For a narrow therapeutic index drug like levothyroxine, “marginal” can be clinically relevant.

---

Why Brand Switching Is Dangerous — The 63% Problem

This is the section your chemist needs to read.

A brand-switching study found that 63% of patients on levothyroxine doses above 100 mcg who were switched to a different brand had abnormal TSH levels within 8 weeks — even though they were perfectly stable on their original brand.

Here is what happens:

1. You’ve been on Thyronorm 100mcg for 2 years. TSH is perfect at 2.1.
2. Your chemist is out of stock. He gives you Eltroxin 100mcg instead. “Same medicine, madam.”
3. The different excipient profile in Eltroxin changes your absorption by 10–15%.
4. Over 4–6 weeks, your T4 drifts. TSH responds.
5. At your next blood test, TSH is 6.8. Your doctor increases the dose to 125 mcg.
6. Now you’re on the wrong dose of the wrong brand. You feel terrible. You blame the disease.

The problem is systemic in India. Chemists routinely substitute brands based on availability or margin — not clinical equivalence. CDSCO does not enforce “do not substitute” policies for narrow therapeutic index drugs the way the FDA does for levothyroxine in the US.

What to do:

• Always ask for the same brand. Tell your chemist explicitly.
• If your brand is unavailable, accept the substitute but inform your endocrinologist and schedule a TSH retest at 6–8 weeks.
• Ask your doctor to write “Do Not Substitute” on the prescription. This is not legally binding in India the way it is in the US, but it signals intent to the pharmacist.
• Stock up. If you find your brand reliably at a specific pharmacy, buy 2–3 months at a time. Levothyroxine tablets have a 2–3 year shelf life if stored correctly.

---

Heat and Storage — India’s Hidden Medication Problem

Levothyroxine is heat-sensitive. The recommended storage temperature is below 25 degrees Celsius, protected from light and moisture.

Now think about the average Indian pharmacy. Un-airconditioned. Metal shutters absorbing direct sunlight. Interior temperatures reaching 40–45 degrees Celsius in summer across most of North and Central India. Medication sitting on shelves for weeks or months.

Your levothyroxine may have lost potency before you bought it.

A study on levothyroxine stability found significant degradation of active ingredient when stored above 30 degrees Celsius for extended periods. The tablet may look identical. The label still reads 100 mcg. But the effective dose could be 80–85 mcg.

This creates a phantom problem: you’re taking your medication correctly, same brand, same time, empty stomach — but your TSH keeps drifting. The doctor adjusts your dose upward. Then in winter (cooler pharmacy, less degradation), you’re suddenly over-replaced.

Practical recommendations:

1. Buy from pharmacies with air conditioning or proper storage
2. Buy from high-turnover pharmacies (fresh stock, not sitting for months)
3. Check the manufacturing date on the bottle — newer is better
4. Store at home in a cool, dry, dark place — never bathroom, never kitchen
5. If you notice your symptoms returning despite compliance, consider that storage degradation may be the cause before accepting a dose increase
6. Apollo Hospitals and other large hospital pharmacies typically have better storage conditions than standalone chemists

---

Drug Interactions — What Destroys Your Levothyroxine

Absorption Reducers (Take 4+ Hours Apart)

Substance	Mechanism	Absorption Reduction
Calcium carbonate (antacids, supplements)	Forms insoluble calcium-T4 complex	~40%
Iron supplements (ferrous sulfate)	Forms insoluble iron-T4 complex	~30–40%
Proton pump inhibitors (omeprazole, pantoprazole)	Reduces gastric acid needed for dissolution	~20–30%
Sucralfate (ulcer medication)	Binds T4 in gut	~30%
Cholestyramine/colestipol (cholesterol drugs)	Binds T4 in bile acid	~50–60%
Aluminum hydroxide (antacids — Digene, Gelusil)	Adsorbs T4	~20–30%
Soy products (soy milk, soy paneer, soy chunks)	Isoflavones block absorption	~15–25%

Medications That Change Levothyroxine Requirements

Drug	Effect	Action
Estrogen (oral contraceptives, HRT)	Increases TBG → more T4 needed	May need dose increase
Phenytoin, carbamazepine (seizure drugs)	Accelerate T4 metabolism	May need dose increase
Rifampin (TB treatment)	Accelerates T4 metabolism	May need significant dose increase
Amiodarone (cardiac drug)	Contains iodine, blocks T4→T3 conversion	Complex — needs specialist management
Sertraline, escitalopram	May slightly increase TSH	Monitor, usually no dose change needed

The Ashwagandha Danger — This Matters for India

Ashwagandha is India’s most popular thyroid “supplement.” Instagram influencers, Ayurvedic practitioners, and even some allopathic doctors recommend it for thyroid support. Here is why this is dangerous when combined with levothyroxine.

The 2018 Sharma et al. double-blind, randomized, placebo-controlled trial found that 600mg of ashwagandha root extract daily:

• Increased serum T3 by 41.5%
• Increased serum T4 by 19.6%
• Decreased TSH by 17.5%

These changes occurred in patients with subclinical hypothyroidism — NOT in euthyroid individuals. The thyroid-stimulating effect was real and measurable.

Now add levothyroxine. You’re already taking a drug that raises T4 and suppresses TSH. Adding ashwagandha — which independently raises T3 and T4 — creates compounding hyperthyroidism risk: palpitations, tremors, anxiety, weight loss, insomnia, bone density loss, and in severe cases, thyroid storm.

The rule is simple: If you’re on levothyroxine, do not take ashwagandha unless your endocrinologist explicitly approves it and increases your monitoring frequency.

---

Side Effects — What to Expect and What to Worry About

When Dose Is Correct (Euthyroid)

Levothyroxine at the correct dose should cause no side effects. You are replacing a hormone your body is missing — bringing levels back to normal. If you’re on the right dose and still symptomatic, the issue may be elsewhere (iron deficiency, B12 deficiency, vitamin D deficiency, depression, sleep apnea).

When Over-Replaced (Too Much Levothyroxine)

These symptoms mean your dose is too high or has become too high (weight loss, improved absorption, added ashwagandha):

Symptom	Mechanism
Heart palpitations / racing heart	Excess T3 increases cardiac contractility
Tremor (shaking hands)	CNS stimulation
Anxiety, nervousness, irritability	Catecholamine sensitization
Insomnia	Increased metabolic rate
Heat intolerance, excessive sweating	Increased thermogenesis
Diarrhea	Increased gut motility
Weight loss (unintentional)	Increased basal metabolic rate
Menstrual irregularity	HPO axis disruption
Bone loss (long-term)	Accelerated bone turnover
Atrial fibrillation (serious)	Cardiac conduction changes

Bone loss deserves special attention. Long-term over-replacement with levothyroxine increases osteoporosis risk, particularly in postmenopausal women. This is one of the strongest arguments against prescribing levothyroxine for mild subclinical hypothyroidism in elderly women — the treatment may cause more harm (fractures) than the disease (mild fatigue).

When Under-Replaced (Too Little Levothyroxine)

Your symptoms of hypothyroidism return or persist:

• Persistent fatigue despite adequate sleep
• Cold intolerance
• Weight gain (gradual, 1–3 kg over months)
• Constipation
• Dry skin, brittle hair
• Brain fog, poor concentration
• Depressive symptoms — hypothyroidism and depression share symptoms and often coexist
• Elevated cholesterol
• Menstrual irregularity (heavy periods)

---

Levothyroxine in Pregnancy — Non-Negotiable

Thyroid hormone is essential for fetal brain development. The fetal thyroid does not begin producing its own hormone until weeks 12–14 of gestation. Before that, the baby depends entirely on maternal T4 crossing the placenta.

Untreated maternal hypothyroidism is associated with:

• 2–3x increased risk of miscarriage
• Preterm delivery
• Low birth weight
• Lower IQ in children (up to 7 IQ points in some studies)
• Gestational hypertension and preeclampsia
• Placental abruption

Pregnancy Management Protocol

1. Pre-conception: TSH should be below 2.5 mIU/L. If you’re planning pregnancy and your TSH is 3.5 on levothyroxine, your dose needs increasing BEFORE conception.
2. Positive pregnancy test: Increase levothyroxine dose by 25–30% immediately (Indian Thyroid Society recommendation). Do not wait for blood test results.
3. First trimester: Recheck TSH every 4 weeks. Target TSH <2.5 mIU/L.
4. Second/third trimester: Target TSH <3.0 mIU/L. Recheck every 4–6 weeks.
5. Post-delivery: Reduce dose back to pre-pregnancy level immediately. Recheck TSH at 6 weeks postpartum.

Typical dose increase: 25–50% above pre-pregnancy dose. A woman on 75 mcg pre-pregnancy may need 100–112 mcg during pregnancy.

Read our pregnancy week-by-week guide for how thyroid management fits into broader prenatal care. If you’re experiencing pregnancy-related complications, thyroid dysfunction should always be on the differential.

---

The Weight Gain Myth — Let’s Kill It

This is the most damaging misconception in Indian thyroid medicine.

The claim: “I’ve gained 20 kg because of my thyroid.”

The reality: Hypothyroidism causes approximately 2–5 kg of weight gain. Most of this is water retention (myxedema), not fat. Correcting thyroid levels with levothyroxine reverses this 2–5 kg over 3–6 months. It does not cause fat loss beyond that.

If you’ve gained 15–25 kg, hypothyroidism contributed perhaps 3–4 kg. The remaining 12–20 kg is from caloric surplus, reduced physical activity, insulin resistance, or other metabolic factors. Levothyroxine will not fix those.

Why this myth persists in India:

1. Hypothyroidism makes you tired and sluggish, reducing spontaneous physical activity — leading to caloric surplus and fat gain over months/years
2. Hypothyroidism slightly reduces basal metabolic rate (200–300 calories/day less) — which compounds over time if caloric intake stays the same
3. Doctors diagnose hypothyroidism and patients attribute ALL their weight gain to it, ignoring dietary and lifestyle factors
4. The thyroid becomes a psychological crutch — “I can’t lose weight because of my thyroid” — even when levels are perfectly controlled on medication

The evidence: Studies consistently show that patients on optimally dosed levothyroxine with normal TSH have the same metabolic rate as people without thyroid disease. If your TSH is normal and you’re still gaining weight, your thyroid is not the cause.

For patients with both hypothyroidism and significant obesity, bariatric surgery may be considered — but only after thyroid levels are optimized and lifestyle interventions have been attempted. Semaglutide (Ozempic) is also being prescribed for weight management in patients with controlled hypothyroidism, though cost and availability in India remain barriers.

---

Jan Aushadhi and Generic Options — The Affordable Alternative

The Indian government’s Jan Aushadhi scheme sells generic levothyroxine sodium at significantly lower prices than branded versions. The quality is equivalent — these generics must meet the same CDSCO bioequivalence and purity standards.

Generic Option	Approximate Price (120 tabs)	Vs. Thyronorm Savings
Jan Aushadhi Levothyroxine 50mcg	₹40–65	40–50% cheaper
Jan Aushadhi Levothyroxine 100mcg	₹55–80	45–55% cheaper

The catch: Narrow therapeutic index. If you switch from branded to generic (or between generics), treat it the same as switching brands — retest TSH at 6–8 weeks. Once stable on a generic, stay on that specific generic manufacturer. Do not bounce between generics based on availability.

Jan Aushadhi stores are present in every district of India. Find your nearest store at janaushadhi.gov.in. For thyroid patients on tight budgets, this can save ₹500–1,000 annually — not transformative, but meaningful for daily-wage workers paying out of pocket.

---

Levothyroxine and Comorbidities

Thyroid + Depression

Hypothyroidism and depression have a bidirectional relationship. Untreated hypothyroidism causes depressive symptoms. Depression can suppress thyroid function. Many patients in India are prescribed escitalopram or other antidepressants for depression that is actually undiagnosed hypothyroidism.

Rule: Every patient presenting with new-onset depression should have TSH checked. If TSH is elevated, correcting thyroid levels may resolve depressive symptoms without antidepressants. If both conditions coexist, treat both — but optimize thyroid first.

Thyroid + Diabetes

Hypothyroidism worsens insulin resistance. Type 1 diabetics have a 15–20% incidence of autoimmune thyroid disease (shared autoimmune predisposition). Type 2 diabetics should have thyroid screening as part of their annual diabetes management.

Metformin, the most prescribed diabetes drug in India, may lower TSH slightly without affecting thyroid hormone levels — this is not clinically significant but can cause confusion on lab reports.

Thyroid + PCOS

Up to 25% of women with PCOS have coexisting thyroid dysfunction. Both conditions cause weight gain, menstrual irregularity, and fatigue. Treating one without screening for the other leads to suboptimal outcomes. If you have PCOS, get a full thyroid panel (TSH, free T4, TPO antibodies), not just TSH.

Thyroid + Cholesterol

Hypothyroidism raises LDL cholesterol by 10–30%. Many Indian patients are prescribed statins for high cholesterol without anyone checking their thyroid. Correcting thyroid levels with levothyroxine often normalizes cholesterol without needing statins. Always check TSH before starting cholesterol medication.

---

When Levothyroxine Alone Is Not Enough

About 10–15% of hypothyroid patients remain symptomatic despite “normal” TSH on levothyroxine. This has generated the T3 controversy:

The T3 Debate

Your body converts T4 (from levothyroxine) to T3 (the active hormone). Some patients have genetic variants in the deiodinase enzymes (particularly DIO2) that impair this conversion. These patients have normal TSH, normal T4, but functionally low T3 at the tissue level.

Current evidence for T4+T3 combination therapy:

• Mixed. Some trials show symptom improvement. Others show no benefit.
• The ATA does not recommend routine T3 addition but acknowledges a subgroup may benefit.
• T3 (liothyronine) has a short half-life, causing peaks and troughs — three-times-daily dosing or sustained-release formulations are needed.
• In India, liothyronine availability is limited and expensive compared to levothyroxine.

What to do if you’re symptomatic despite normal TSH:

1. Ensure TSH is in the lower half of reference range (0.5–2.5, not just <4.5)
2. Check free T3 — if low-normal, the conversion issue may be real
3. Rule out iron deficiency, B12 deficiency, vitamin D deficiency — all cause fatigue and overlap with thyroid symptoms. A CBC test can identify several of these.
4. Rule out depression, sleep apnea, celiac disease
5. Discuss T3 trial with an endocrinologist (not a GP) — if attempted, monitor carefully

---

How to Monitor Levothyroxine — The Right Blood Tests at the Right Time

Situation	Test	Timing
New diagnosis / starting treatment	TSH + Free T4	Baseline, then 6–8 weeks
Dose adjustment	TSH + Free T4	6–8 weeks after change
Stable dose	TSH alone	Every 6–12 months
Pregnancy	TSH + Free T4	Every 4 weeks (1st trimester), every 6 weeks after
Suspected over/under-replacement	TSH + Free T4 + Free T3	At symptom onset
New hypothyroidism diagnosis	TSH + Free T4 + TPO antibodies	Once (to confirm Hashimoto’s)
Brand switch	TSH + Free T4	6–8 weeks after switch

Avoid testing TSH within 6 weeks of a dose change — the result will not reflect your true steady-state levels and may lead to premature, incorrect dose adjustments.

Morning blood draw preferred. TSH has a circadian rhythm — highest in early morning, lowest in afternoon. Afternoon testing can show falsely lower TSH, leading to under-dosing.

Do not take your levothyroxine dose on the morning of the blood test. Take it after the blood draw. This avoids a post-dose T4 spike that could falsely elevate your free T4 reading.

Cost of monitoring in India: TSH alone costs ₹200–500 at most private labs. Full thyroid panel (TSH + T3 + T4) costs ₹400–1,000. This is affordable enough to test properly — there is no excuse for adjusting doses without blood confirmation. Connect with qualified endocrinologists who follow evidence-based monitoring protocols.

---

Common Mistakes That Sabotage Treatment

Mistake 1: Taking Levothyroxine with Chai, Milk, or Coffee

Already covered above, but worth repeating because it is the single most common reason for unexplained TSH elevation in Indian patients.

Mistake 2: Storing Medication in Humid or Hot Environments

Indian kitchens and bathrooms are the worst places for medication. Heat + humidity = degraded drug.

Mistake 3: Accepting Brand Substitution from the Chemist

“Same-same, madam” is not a pharmacological argument. Demand your prescribed brand.

Mistake 4: Taking Calcium, Iron, or Antacids at the Same Time

Separate by 4 hours. This includes seemingly harmless things like Digene, Gelusil, and Shelcal.

Mistake 5: Retesting TSH Too Early

Testing at 3–4 weeks and adjusting dose creates a cycle of over-correction and instability. Wait 6–8 weeks.

Mistake 6: Stopping Medication Because “I Feel Fine”

Feeling fine is the levothyroxine working. Stopping it means symptoms return within weeks.

Mistake 7: Using Ashwagandha Supplements Without Informing Your Doctor

The T3/T4-boosting effect is real and documented. Combined with levothyroxine, it can cause iatrogenic hyperthyroidism.

Mistake 8: Chasing a “Perfect” TSH Number

TSH 1.5 is not inherently better than TSH 3.0. The target is symptom resolution within the normal range, not a specific number. Over-optimizing TSH causes over-replacement.

---

Sources & References

1. Effect of brand interchange of levothyroxine on TSH levels — PMC/NIH (2019). https://pmc.ncbi.nlm.nih.gov/articles/PMC6166548/
2. Cochrane Database — Levothyroxine treatment for subclinical hypothyroidism (2023). https://doi.org/10.1002/14651858.CD003419.pub3
3. Sharma AK et al. — Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC5871210/
4. Indian Thyroid Society — Guidelines for Management of Hypothyroidism in Adults (2022). https://www.indianthyroidsociety.com
5. Prevalence of hypothyroidism in India: An epidemiological study — PMC/NIH (2013). https://pmc.ncbi.nlm.nih.gov/articles/PMC3743356/
6. ATA/AACE Clinical Practice Guidelines for Hypothyroidism in Adults (2012, updated 2014). https://www.liebertpub.com/doi/10.1089/thy.2012.0235
7. CDSCO — Approved drug list and bioequivalence requirements. https://cdsco.gov.in
8. Jan Aushadhi — Generic medicine price list 2025-26. https://janaushadhi.gov.in

---

This article is for informational purposes only and does not constitute medical advice. Reviewed by healthcare professionals. Never start, stop, or change the dosage of levothyroxine without consulting your endocrinologist. Thyroid conditions require ongoing medical supervision — self-medicating based on online information, including this article, can cause serious harm. If you suspect thyroid dysfunction, get a TSH blood test and consult a qualified endocrinologist.